Mobileye (MBLY) Q3 2026 Earnings Call Transcript

Mobileye reported Q3 revenue of $492 million, down 2% year over year, while EyeQ shipments rose 3% to 9.5 million units and adjusted operating income increased 20% to $89 million. Management raised full-year revenue guidance by $13 million at the midpoint to $1.995 billion–$2.020 billion and adjusted operating income guidance to $380 million–$420 million; the outlook includes an estimated $190 million Israeli R&D incentive. Offsetting factors include non-GAAP gross margin falling to 64% from 67%, expected Q4 EyeQ shipments of 8.8 million–8.9 million, and management’s warning of possible inventory-driven demand volatility. Mobileye also reported $303 million in operating cash flow for the first nine months and $33 million in share repurchases since April.

Analysis

The earnings signal is better on share capture than on near-term monetization. EyeQ gains despite weak production suggest Mobileye is winning content, but lower-priced Chinese export mix converts those units into weaker revenue and ASP; that channel also carries longer-term localization and competitive-substitution risk. The market should distinguish share gains from pricing power.

Profitability quality is the key caveat: roughly half of midpoint adjusted operating income guidance is attributable to the Israeli R&D incentive. It supports reported earnings, not equivalent product-level margin improvement; cash realization is delayed, and qualification, FX, or legislative changes can move the benefit. Separately, memory pass-through protects dollars of revenue but adds no gross profit, while richer SuperVision mix dilutes corporate gross margin. More systems sold is not automatically more earnings.

Over 1–3 months, the guided Q4 shipment decline and possible inventory normalization are the main downside catalysts; the sequential step-down is disclosed, so a miss below the 8.8–8.9 million EyeQ range would be more informative than the decline itself. Over 6–18 months, Surround ADAS and cloud software can lift content per vehicle, but meaningful conversion depends on production starts and take rates, not design wins. Volkswagen program execution is a nearer proof point; future VW architecture remains contestable. The 100-vehicle robotaxi plan is strategically useful for product control, but early one-operator-per-vehicle economics and GPU investment make it a cost and execution risk, not yet a valuation anchor.

Key Decisions for Investors

• Do not chase MBLY solely on the volume beat. Treat the current setup as a conditional accumulation: add on weakness only if Q4 EyeQ shipments stay within or above guidance and subsequent customer commentary does not indicate a deeper inventory correction.
• For the next earnings update, track adjusted operating income excluding the R&D incentive, gross-margin direction, and memory-cost recovery separately. A weakening credit-neutral trend or failure to recover memory costs would invalidate the improving-earnings-quality thesis.
• Keep 2028 ASP expansion as a watch item, not a base-case catalyst, until OEM production timing and adoption volumes are independently clearer. Design wins alone do not establish revenue scale or consolidated margin accretion.
• Avoid treating Tesla’s FSD take-rate commentary as direct evidence of MBLY share gains: it may validate category demand, but MBLY still must demonstrate production performance and OEM conversion.